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LANDONI ET AL2decontamination of the gastrointestinal tract, insulin
for tight glycemic control, preoperative intra-aortic bal-
loon pump, leuko-depleted red blood cells transfusion,
levosimendan, volatile agents, and remote ischemic pre-
conditioning) and 2 interventions showing increased
mortality (beta-blocker therapy and aprotinin). Interven-
tions then were voted on by participating clinicians.
Percentages of agreement among clinicians in different
countries differed signiﬁcantly for 6 interventions, anda variable gap between evidence and clinical practice
was noted.
Conclusions: The authors identiﬁed 13 nonsurgical inter-
ventions that may decrease or increase perioperative mor-
tality, with variable agreement by clinicians. Such
interventions may be optimal candidates for investigation
in high-quality trials and discussion in international guide-
lines to reduce perioperative mortality.
& 2016 Elsevier Inc. All rights reserved.ALL SURGICAL PROCEDURES are associated with acertain risk of both intraoperative and postoperative
adverse events that in some cases can be fatal. However,
perioperative mortality generally is perceived as relatively low,
especially at individual center level and for elective noncardiac
surgery in patients without particular risk proﬁles. Overall all-
cause mortality after noncardiac surgery has been reported to
be 1% to 4%.1 Moreover, due to the relatively low mortality
rate and the complexity of the clinical setting, it is not easy to
investigate the impact of therapeutic interventions, which could
have signiﬁcant, though small, effects on perioperative mortal-
ity. Accordingly, this matter has never received great attention
in the medical literature.2 However, of the more than 230 million
patients who undergo major surgical procedures worldwide every
year, more than 1 million die within 30 days.3 Thus, even small
reductions in perioperative mortality may save many lives.
To achieve a comprehensive view of this issue and to better
understand which drugs, techniques, or strategies should be
used (or avoided) by clinicians in an effort to reduce mortality,
large collaborative research projects are required and a system-
atic and effective identiﬁcation of the interventions that
potentially may affect mortality is vital.
Since 2010, the authors have developed an innovative
approach to consensus that allowed them to accomplish a
comprehensive and widely agreed upon overview of interven-
tions that might affect mortality in different clinical settings,
including the perioperative period of any surgical procedure,
cardiac surgery, critically ill patients, and acute kidney injury.4–8
Because evidence seems to be evolving constantly and rapidly,
the authors conducted an update of a previous consensus process
on ancillary (nonsurgical) interventions (drugs/techniques/
strategies) that have been shown by at least 1 randomized
controlled trial (RCT) or meta-analysis of RCTs to affect
perioperative mortality in any adult surgical setting. In addition
to a systematic literature search, consensus meeting, and web-
based survey about the agreement on the included interventions,
the authors investigated the reported use of such interventions in
clinical practice and the possible gap between literature evidence
and clinical practice. Furthermore, comparison with the previous
consensus process gave the opportunity to appreciate how
rapidly evidence has evolved.
METHODS
A systematic MEDLINE/PubMed, Scopus, and Embase
search with no time limits that was updated March 6, 2015,
was performed by 4 experienced investigators (GL, AP, AB,
LR) to identify all of the published literature with randomized
evidence of mortality reduction or increase in the perioperative
period (see Appendix 1 for the full search strategy). Theauthors found additional articles through a cross-check of
references and suggestions by experts in the ﬁeld of perioper-
ative medicine. A website allowed participants worldwide to
vote in support of or against the nominated interventions and to
submit comments or to report additional articles for inclusion
until the day of the consensus meeting.
Only the studies that satisﬁed all the following criteria were
considered: (1) publication in a peer-reviewed journal, (2)
assessment of a nonsurgical intervention (drug/technique/strat-
egy) in adult patients undergoing any type of surgery, (3)
achievement of a statistically signiﬁcant reduction or increase
in mortality, and (4) conducted as randomized trial or meta-
analysis of RCTs.
The in-person meeting was held March 6, 2015, at the Vita-
Salute University, Milan, Italy, and involved anesthesiologists,
intensive care specialists, cardiologists, surgeons, and epidemi-
ologists. During this face-to-face consensus conference, for
each intervention, participants were asked to decide whether (1)
the most recent evidence had been collected, (2) the effect on
mortality was supported by RCTs or meta-analyses of RCTs,
(3) the supporting evidence was derived from a primary or a
subgroup analysis, (4) the evidence was derived entirely or
partially from a surgical population, (5) the intervention was
applicable to all patients or to subgroups only, and (6) mortality
was the study endpoint or was included in a composite
endpoint.
Each intervention was presented by a rapporteur and
commented on by 1 or 2 discussants; the consensus process
involved the international cohort of participants who voted on
the interventions before and after the Milan meeting. A position
statement was approved describing the reasons for the inclu-
sion. The studies or interventions that did not meet the
aforementioned criteria became major exclusions, and reasons
for exclusion were detailed (Tables S1 and S2).
The ﬁnal interventions and their statements were presented
online at the website www.democracybasedmedicine.org
(Table 1). Participants worldwide had the opportunity, through
the web survey, to support or challenge the interventions and
statements from the meeting for the 5 months between March
and August 2015. The following 3 questions were asked: (1)
Do you agree with this sentence? (Yes/No/Do not know); (2)
Do you routinely use this intervention in your clinical practice?
(Yes/No/Does not apply); (3) Would you include this inter-
vention into future international guidelines to reduce perioper-
ative mortality? (Yes/No/Do not know)
For the interventions increasing mortality, the second and third
questions were asked in an opposite fashion: Do you routinely
avoid this intervention in your clinical practice? Would you
suggest that future international guidelines should contraindicate
Table 1. Topics (Drugs and/or Nonsurgical Techniques or Strategies) With Randomized Published Evidence of a Reduction/Increase in
Perioperative Mortality
Topics Sentences Agreement
Increasing survival
Perioperative hemodynamic
optimization
According to 5 meta-analyses of RCTs, perioperative hemodynamic optimization can reduce
mortality in high-risk surgical patients. Uncertainty remains about which invasive devices and/or
therapeutic interventions are to be preferred. This topic merits further investigation.
95%
Do you agree with the above sentence?
Insulin glycemic control According to 2 RCTs and 1 meta-analysis of RCTs, continuous insulin infusion can reduce
perioperative mortality. The ideal glycemic target is still to be determined and might change in
different settings. The authors strongly recommend caution when using tight glycemic control
because of the risk of hypoglycemic episodes. This topic merits further investigation.
88%
Do you agree with the above sentence?
Noninvasive ventilation According to 3 small RCTs, noninvasive ventilation reduces mortality in acute respiratory failure after
solid organ transplantation, lung resection, and cardiac surgery. This topic merits further
investigation.
88%
Do you agree with the above sentence?
Levosimendan According to 1 small RCT and 4 meta-analyses of RCTs, levosimendan may reduce 30-day mortality
in patients with low ejection fraction undergoing cardiac surgery. This topic merits further
investigation.
88%
Do you agree with the above sentence?
Leuko-depleted red blood
cells transfusion
According to 2 RCTs, patients undergoing cardiac surgery might beneﬁt from leukocyte depletion of
transfused blood by ﬁltration. This topic merits further investigation.
86%
Do you agree with the above sentence?
Preoperative IABP According to 1 small RCT and 4 meta-analyses of RCTs, preoperative IABP can have a beneﬁcial
effect on mortality in speciﬁc high-risk patient groups undergoing CABG. This topic merits further
investigation.
85%
Do you agree with the above sentence?
Volatile agents According to 2 meta-analyses of RCTs, volatile anesthetics might reduce 30-day mortality in patients
undergoing coronary artery bypass graft surgery. This topic merits further investigation.
85%
Do you agree with the above sentence?
Tranexamic acid According to 1 meta-analysis of RCTs, low-dose tranexamic acid may reduce mortality. This topic
merits further investigation.
84%
Do you agree with the above sentence?
Neuraxial anesthesia According to 4 meta-analyses of RCTs, neuraxial anesthesia may reduce short-term mortality
compared with general anesthesia in noncardiac surgery. This topic merits further investigation.
81%
Do you agree with the above sentence?
Remote ischemic
preconditioning
According to 1 RCT, remote ischemic preconditioning provides perioperative myocardial protection
and might improve late survival in patients undergoing elective coronary artery bypass grafting
surgery. This topic merits further investigation.
80%
Do you agree with the above sentence?
Selective decontamination
of digestive tract
According to 1 meta-analysis of RCTs, selective decontamination of the digestive tract in critically ill
surgical patients might reduce mortality. This topic merits further investigation.
67%
Do you agree with the above sentence?
Increasing mortality
Beta-blockers According to 1 large RCT and 3 meta-analyses, beta-blockers started immediately before noncardiac
surgery can increase perioperative mortality in patients with, or at risk for, atherosclerotic disease.
Nonetheless, the consensus conference recommends to maintain chronic beta-blocker therapy in
the perioperative period.
83%
Do you agree with the above sentence?
Aprotinin According to 1 RCT, aprotinin increases 30-day mortality in adult patients undergoing cardiac
surgery.
73%
Do you agree with the above sentence?
Abbreviations: CABG, coronary artery bypass grafting; IABP, intra-aortic balloon pump; RCT, randomized controlled trial.
UPDATED CONSENSUS ON INTERVENTIONS TO REDUCE PERIOPERATIVE MORTALITY 3this intervention to reduce perioperative mortality? The authors did
not include the possibility to “partially agree” with a statement;
therefore, every answer refered to the full sentence. The option to
answer “do not know” was included in the questionnaire to allow
responders to state that they had no opinion or had never thought
about that particular issue. Because methodologic research suggests,
as previously mentioned,6,8 that there is no difference in responserate depending on the inclusion or exclusion of the “do not know”
option (if less than 40%),9 only the “yes” and “no” frequencies
were reported in the results if not otherwise indicated.
After the second and last web vote, the interventions that
reached less than 67% of agreement were considered as major
exclusions (see Tables S1 and S2). The interventions with an
impact on mortality that were approved after the web vote, with
Table 2. Randomized Clinical Trials and Meta-Analyses of Randomized Clinical Trials Documenting a Mortality Reduction or an Increase in Mortality in the Postoperative Period
Topics Improving Survival First Author Journal Year
RCT or META
of RCTs
Number of Randomly
Assigned Patients Country
Increasing Survival
Perioperative hemodynamic optimization Cecconi et al.10 Crit Care 2013 Meta-analysis 315 United Kingdom
Gurgel et al.11 Anesth Analg 2011 Meta-analysis 5,056 Brazil
Hamilton et al.12 Anesth Analg 2011 Meta-analysis 4,805 United Kingdom
Brienza et al.13 Crit Care Med 2009 Meta-analysis 4,220 Italy
Poeze et al.14 Crit Care Med 2005 Meta-analysis 5,733 Netherlands
Insulin for glycemic control Giakoumidakis et al.15 Heart Lung 2012 RCT 212 Greece
Haga et al.16 J Cardiothorac Surg 2011 Meta-analysis 1,492 United Kingdom
Van den Berghe et al.17 N Engl J Med 2001 RCT 1,548 Belgium
Noninvasive ventilation Zhu et al.18 Chin Med J 2013 RCT 95 China
Auriant et al.19 Am J Respir Crit Care Med 2001 RCT 48 France
Antonelli et al.20 JAMA 2000 RCT 40 Italy
Levosimendan Harrison et al.21 J Cardiothorac Vasc Anesth 2013 Meta-analysis 1,155 United States
Landoni et al.22 Crit Care Med 2012 Meta-analysis 5,480 Italy
Maharaj and Metaxa.23 Crit Care 2011 Meta-analysis 729 United Kingdom
Landoni et al.24 J Cardiothorac Vasc Anesth 2010 Meta-analysis 440 Italy
Levin et al.25 Rev Esp Cardiol 2008 RCT 137 Argentina
Leuko-depleted red blood cell transfusion Bilgin et al.26 Circulation 2004 RCT 474 Netherlands
Van de Watering et al.27 Circulation 1998 RCT 914 Netherlands
Preoperative IABP in high-risk CABG Zangrillo et al.28 Crit Care 2015 Meta-analysis 625 Italy
Sá et al.29 Coron Artery Dis 2012 Meta-analysis 345 Brazil
Theologou et al.30 Cochrane Database Syst Rev 2011 Meta-analysis 255 United Kingdom
Qiu et al.31 J Cardiothorac Surg 2009 RCT 221 China
Dyub et al.32 J Card Surg 2008 Meta-analysis 2,363 Canada
Volatile agents Landoni et al.33 Br J Anaesth 2013 Meta-analysis 3,642 Italy
Landoni et al.34 J Cardiothorac Vasc Anesth 2007 Meta-analysis 1,922 Italy
Tranexamic acid Ker et al.35 BMJ 2012 Meta-analysis 10,488 United Kingdom
Neuraxial anesthesia Guay et al.36,37 Anesth Analg, Cochrane Database Syst Rev 2014 Meta-analysis 3,006 Canada
Pöpping et al.38 Ann Surg 2014 Meta-analysis 2,201 Germany
Rodgers et al.39 BMJ 2000 Meta-analysis 9,559 New Zealand
Urwin et al.40 Br J Anaesth 2000 Meta-analysis 1,578 United Kingdom
Remote ischemic preconditioning Thielmann et al.41 Lancet 2013 RCT 329 Germany
Selective decontamination of the
digestive tract
Nathens and Marshall.42 Arch Surg 1999 Meta-analysis Not available Canada
Increasing mortality
Beta-blockers Wijeysundera et al.43,44 Circulation, J Am Coll Cardiol 2014 Meta-analysis 12,391 Canada, United States
Blessberger et al.45 Cochrane Database Syst Rev 2014 Meta-analysis 19,211 Austria
Devereaux et al.46 Lancet 2008 RCT 8,351 Canada
Bouri et al.47 Heart 2014 Meta-analysis 10,529 United Kingdom
Aprotinin Fergusson et al.48 N Engl J Med 2008 RCT 2,331 Canada
Abbreviations: CABG, coronary artery bypass grafting; IABP, intra-aortic balloon pump; META, meta-analysis; RCT, randomized clinical trial.
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Table 3. Number of Voters from Each Country and Number of
Anesthesiologist and/or Intensive Care Physicians Among Voters
Number of voters Percentage
Country
Australia 56 11%
Italy 50 10%
United Kingdom 37 7%
Other Western countries 170 34%
Other countries 187 37%
Total 500 100%
Profession
Anesthesiologist and/or intensive
care physician
411 82%
Others 89 18%
Total 500 100%
UPDATED CONSENSUS ON INTERVENTIONS TO REDUCE PERIOPERATIVE MORTALITY 5the references to the articles of RCTs or meta-analyses of RCTs
supporting the evidence, are reported in Table 2 if over-
whelming evidence was not published thereafter.
Throughout the process, all participants (either those voting
via web or those participating in person) were asked to disclose
all potential conﬂicts of interest. Analyses were repeated to
include only answers without conﬂict of interests. There was no
sponsor or industry support for this consensus conference.
Subanalyses were performed by country, to assess the
relationship between the clinicians’ opinion and the source
of the evidence, and by the responders’ specialty, to assess
whether the approach to perioperative management dif-
fered among specialists in anesthesia and other healthcare
professionals.
The gap between agreement and practice was measured by
calculating the ratio of all the answers with consistency
between agreement and use or avoidance in clinical practice
over the total number of responses. Double votes were
prevented by using the e-mail ﬁeld as the unique identiﬁer.
The ClinicalTrials.gov register for each intervention on the
ﬁnal list was surveyed to assess the current level of interest for
testing each identiﬁed intervention.
Statistical Analysis
From the data provided in the articles, the relative risk
reduction or increase, absolute risk reduction or increase, and
number needed to treat or harm were calculated. The results of
the web vote are expressed as percentage of positive votes. The
percentage of agreement of the following data are reported: (1)
selected literature; (2) use/avoidance in clinical practice; and (3)
inclusion in future guidelines. Statistical analysis was performed
using Stata 13 software (StataCorp, College Station, TX).
The chi-square or Fisher exact test was used to evaluate
differences in percentages among countries and specialists.
Statistical signiﬁcance was set at po 0.05.
RESULTS
Thirteen interventions were selected by 500 clinicians from
61 countries. The 13 interventions selected using the web
survey were supported by 39 articles10–48 (12 RCTs and 27
meta-analyses of RCTs). The following 11 interventions10–42
were reported to increase survival: perioperative hemodynamic
optimization in high-risk surgical patients, neuraxial anesthesia
compared with general anesthesia, noninvasive ventilation in
acute respiratory failure, tranexamic acid, and selective decon-
tamination of the gastrointestinal tract in critically ill patients—
all in noncardiac surgery; insulin for tight glycemic control,
preoperative intra-aortic balloon pump (IABP) in high-risk
patients undergoing coronary artery bypass graft surgery,
leuko-depleted red blood cells transfusion, levosimendan in
patients with low ejection fraction, volatile agents, and remote
ischemic preconditioning (RIPC) in patients undergoing coro-
nary artery bypass graft surgery—all in cardiac surgery.
The 2 interventions found to increase mortality were the use
of beta-blocker therapy in the immediate preoperative period of
noncardiac surgery and the administration of aprotinin in
cardiac surgery patients.43–48 The following countries included
in the study had the highest number of voters: Australia, Italy,and the United Kingdom. Most participants were specialized in
anesthesiology and intensive care (Table 3).
The articles were published between 1998 and 2015, with
an increase in the number of articles in recent years and an
increase in the studies’ sample size (Fig 1). When focusing on
RCTs, and therefore excluding meta-analyses of RCTs, a
limited trend toward the number of patients included and in
the number of centers included over the 16 years (1998-2013)
were observed (Tables S3 and S4; Fig S1).
The journals that published the 39 articles with differences
in mortality are reported in Table 4. The most frequent
origins of the publishing authors were Canada, Italy, and the
United Kingdom with 7 manuscripts each; authors from
Canada, The Netherlands, and China published the highest
number of RCTs (Table S5).
The percentages of agreement of the web voters with the
previously identiﬁed interventions and their supporting state-
ments ranged between 95% for perioperative hemodynamic
optimization to 67% for selective decontamination of the
digestive tract (see Table 1). The percentage of agreement
among specialists of different countries was not statistically
different for 8 of the 13 interventions, with the highest
concordance seen for volatile agents (Table 5). There was no
concordance in the other 5 of the 13 interventions (see
Table 5). The consistency between agreement and practice
varied from 79% for volatile agents to 35% for RIPC (Table 6).
The routine use of each drug/technique/strategy always was
lower than the agreement for the same type of intervention. The
less-used interventions were selective decontamination of the
digestive tract (15%) and remote ischemic preconditioning
(22%), and the most used were volatile agents (80%) and
preoperative hemodynamic optimization (74%). Aprotinin was
the most avoided intervention (78%) and the only intervention
in which clinical practice exceeded the agreement (Table 5).
Statistically signiﬁcant differences among represented countries
in the use or avoidance of the interventions were observed for
8 of the 13 interventions (Table 5). When asked whether
the interventions should be included in future guidelines, there
was a general agreement above 67% for 10 interventions.
Interestingly, opinions among the represented countries about
the necessity of including interventions into future guidelines
always were statistically signiﬁcantly different for strategies
Consensus Conference
19633 papers were studied
19548 papers were 
excluded due to lack of 
inclusion criteria
85 papers studied in detail
Reducing mortality:33 papers
Perioperative haemodynamic optimisation
Neuraxial anaesthesia
Volatile agents
Preoperative IABP in high-risk CABG
Insulin for glycemic control
Non-invasive ventilation 
Levosimendan
Selective decontamination of the digestive tract
Leuko-depleted red blood cell transfusion
Remote ischaemic preconditioning
Tranexamic acid
Increasing mortality: 6 papers
Beta-blockers
Aprotinin
10 further papers were excluded due to 
prespecified exclusion criteria
75 papers discussed in the 
final meeting
13 topics (16 papers) considered major exclusions
+
12 papers excluded from 2nd Web vote even if the 
topic was included
2 papers considered screening failure and excluded
1st 
Web 
Vote
Systematic 
literature 
review
2nd Web Vote:
14 drugs/techniques/strategies (42 papers)  
considered to have an impact on mortality in the 
perioperative setting, as voted by 500 participants 
from 61 countries: 3 topics (7 papers) were excluded by 
the web vote or due to overwhelming 
recent high-quality evidence showing 
no benefit or possible harm
Liberal transfusion strategy
MECC (minimal 
extracorporeal circulation)
Statins
Fig 1. Flow chart on the web-based conference and selection of the interventions with an effect on mortality in the perioperative setting.
LANDONI ET AL6increasing survival, whereas no difference was observed for
interventions increasing mortality.
When comparing the opinions of anesthesiologists and
intensive care specialists with other healthcare professionals
about interventions reducing perioperative mortality, no statisti-
cally signiﬁcant differences were observed. Conversely, for the
interventions that might increase perioperative mortality (beta-
blocker therapy and the use of aprotinin), intensive care
specialists reported statistically signiﬁcantly higher percentages
of avoidance compared with other specialists (Table S6).Declarations of a potential conﬂict of interest for each of the
interventions ranged from 0% to 1.2%, and the exclusion of
these participants did not affect the results.
Several major study exclusions were identiﬁed and are
reported in Tables S1 and S2, with the reason for exclusion.
Notably, 2 interventions that reached the ﬁnal stage of the web
vote were excluded because they did not reach the minimum
general agreement, set at 67%. In fact, the percentage of
agreement was 55% for liberal transfusion strategy and only
42% for minimal extracorporeal circulation. One intervention
Table 4. Number of Articles Published by Each Journal
Journal Number of Articles
Anesth Analg 3
Circulation 3
Cochrane Database Syst Rev 3
Crit Care 3
Crit Care Med 3
J Cardiothorac Surg 3
J Cardiothorac Vasc Anesth 3
Br J Anaesth 2
BMJ 2
Lancet 2
N Engl J Med 2
Am J Respir Crit Care Med 1
Ann Surg 1
Arch Surg 1
Chin Med J 1
Coron Artery Dis 1
Heart 1
Heart Lung 1
J Am Coll Cardiol 1
JAMA 1
Rev Esp Cardiol 1
UPDATED CONSENSUS ON INTERVENTIONS TO REDUCE PERIOPERATIVE MORTALITY 7(preoperative statin therapy in statin-naïve patients)49–51 was
excluded after completion of the web vote because large, high-
quality RCTs showing no beneﬁt and possible harm were
published thereafter.52,53
The list of the 132 ongoing trials identiﬁed on the
ClinicalTrials.gov register for the 13 interventions is provided
in Table S7, with different interests shown among the interna-
tional community, ranging from 36 ongoing trials on perioper-
ative tranexamic acid to no studies on aprotinin and leuko-
depleted red blood cells transfusion.DISCUSSION
Key Findings
The authors identiﬁed all nonsurgical interventions (drugs,
techniques, or strategies) that have been shown by at least 1
RCT or meta-analysis of RCTs to affect mortality signiﬁcantly
in the perioperative period of any adult surgery. Moreover, the
authors analyzed how these interventions are regarded by a
large cohort of colleagues worldwide and to what extent they
translate into reported clinical practice. Through a well-proven
“democratic” consensus process that has been described
widely,4–8,54 the systematic review of literature was limited to
the highest levels of evidence-based medicine (EBM) hierarchy
and ﬁltered through the views and experience of 500 clinicians
from 61 countries. This is a unique feature of this consensus
process, which allows physicians to directly provide their
opinion on perioperative interventions associated with an
increase or reduction in survival. In this way, the authors were
able to determine the level of interest and perceived importance
of these interventions. As such, it may become a pragmatic
(patients’) “survival guide” to be used by anesthesiologists,
intensivists, and other specialists in their daily practice.
Interestingly, the authors found differences among different
countries and, only in a few cases, among different specialists.Finally, this study provided the opportunity to analyze
the existing gap between medical literature and clinical practice
in the complex ﬁeld of perioperative medicine. Furthermore, as
an update of the consensus process conducted in 2011,5 it
allowed for an assessment of how rapidly EBM evolved,
suggesting the need for continuous and quick updating
(not only of literature, but also of industry beliefs) and for
the conduct of high-quality RCTs focused on major outcomes
such as mortality.Relationship to Previous Literature
The present ﬁndings were of particular interest when
compared with those of the ﬁrst international web-based
consensus process on perioperative mortality, which was held
in 2011 and results of which were published in 2012.5
Although the number of interventions identiﬁed was almost
the same, 3 of the 13 interventions that were included
previously were excluded in the present update (chlorhexidine
oral rinse, α2-adrenergic agonists, and perioperative supple-
mental oxygen), whereas 2 new interventions were included
(tranexamic acid and RIPC). Chlorhexidine oral rinse and
α2-adrenergic agonists were excluded due to the publication
of subsequent studies not conﬁrming a survival beneﬁt55 or
even reporting, in contrast to previous investigations, an
increase in mortality.56 The presence of conﬂicting results of
the 2 identiﬁed studies57,58 in addition to low agreement and the
lack of a convincing underlying mechanism59,60 were the main
reasons for the exclusion of perioperative supplemental oxygen.
Regarding the 2 new interventions included, additional cor-
roborating evidence has become available for tranexamic acid,
which previously was excluded due to the lack of clear evidence
of a survival beneﬁt in the perioperative period, and the only trial
suggesting a reduction in mortality with RIPC41 had not yet been
published at the time of the ﬁrst consensus process.
The authors also found an increased number of studies in
support of a favorable effect on mortality for 6 of the 9
interventions that have been conﬁrmed to improve survival:
neuraxial anesthesia, volatile agents, insulin for glycemic
control, noninvasive ventilation, levosimendan, and preoper-
ative IABP. In particular, the number of supporting studies has
risen dramatically (from 1 to 5) for the last 2 interventions.
Regarding interventions reducing survival, the number of
supporting studies has increased greatly (from 1 to 4) for beta-
blockers.
Another interesting comparison was with the similar con-
sensus process conducted to identify interventions that can
affect mortality in critically ill patients.7 The same therapeutic
intervention can be beneﬁcial in a clinical setting and harmful
in another. In fact, both intensive insulin therapy and hemody-
namic optimization (with supranormal oxygen delivery as a
target) have been found possibly to be life-saving in the
perioperative period and to potentially increase mortality in
critically ill patients. Furthermore, intensive insulin therapy
might be beneﬁcial only among cardiac surgery patients but
not among those undergoing noncardiac interventions, as
suggested by the Normoglycaemia in Intensive Care Evaluation
and Survival Using Glucose Algorithm Regulation (NICE-
SUGAR) trial.61
Table 5. Percentages of Agreement and Use of the Interventions Identiﬁed as Increasing Survival or Mortality Overall and Divided by Countries
Intervention Question Total Australia Italy United Kingdom Other Western Country Other p Value
Increasing survival
Perioperative hemodynamic optimization Agree 95% 85% 98% 94% 94% 98% 0.001
Use 70% 38% 88% 70% 70% 74% o0.001
Guidelines 89% 67% 94% 85% 88% 95% o0.001
Insulin for glycemic control Agree 88% 78% 88% 83% 91% 91% 0.068
Use 66% 49% 70% 66% 64% 71% 0.061
Guidelines 76% 57% 74% 65% 74% 86% 0.001
Noninvasive ventilation Agree 88% 95% 98% 95% 85% 85% 0.047
Use 56% 42% 80% 48% 57% 54% 0.007
Guidelines 77% 70% 95% 83% 69% 80% 0.008
Levosimendan Agree 88% 81% 98% 88% 86% 88% 0.176
Use 41% 13% 82% 16% 42% 40% o0.001
Guidelines 67% 39% 86% 67% 62% 73% 0.001
Leuko-depleted red blood cell transfusion Agree 86% 76% 84% 95% 87% 89% 0.220
Use 52% 66% 39% 29% 63% 45% 0.001
Guidelines 77% 68% 65% 70% 75% 85% 0.037
Preoperative IABP in high-risk CABG Agree 85% 73% 98% 88% 78% 90% 0.001
Use 46% 22% 71% 57% 37% 51% o0.001
Guidelines 69% 45% 88% 70% 54% 82% 0.000
Volatile agents Agree 85% 88% 87% 83% 84% 84% 0.965
Use 76% 75% 67% 65% 76% 80% 0.357
Guidelines 75% 58% 84% 71% 70% 82% 0.019
Tranexamic acid Agree 84% 82% 86% 84% 86% 80% 0.746
Use 65% 39% 65% 65% 74% 66% o0.001
Guidelines 65% 39% 65% 65% 74% 66% 0.011
Neuraxial anesthesia Agree 81% 75% 89% 69% 79% 84% 0.123
Use 65% 46% 60% 60% 70% 70% 0.021
Guidelines 74% 57% 72% 64% 74% 82% 0.012
Remote ischemic preconditioning Agree 80% 90% 75% 81% 76% 83% 0.333
Use 12% 0% 13% 0% 6% 22% o0.001
Guidelines 47% 22% 52% 56% 37% 61% 0.001
Decontamination of the digestive tract Agree 67% 61% 82% 72% 68% 62% 0.136
Use 14% 4% 22% 10% 16% 15% 0.142
Guidelines 45% 31% 54% 65% 40% 46% 0.045
Increasing mortality
Beta-blockers Agree 83% 88% 76% 83% 89% 78% 0.055
Avoid 57% 57% 59% 56% 65% 49% 0.087
Guidelines 70% 61% 80% 66% 70% 71% 0.386
Aprotinin Agree 73% 87% 94% 44% 70% 69% o0.001
Avoid 77% 71% 65% 52% 84% 78% 0.010
Guidelines 67% 74% 65% 59% 64% 69% 0.733
NOTE. Agree: Do you agree with the above sentence? Use/Avoid: Do you routinely use/avoid this intervention in your clinical practice?
Guidelines: Would you include this intervention into future international guidelines to reduce perioperative mortality?/Would you suggest that
future international guidelines should contraindicate this intervention to reduce perioperative mortality?
Abbreviations: CABG, coronary artery bypass grafting; IABP, intra-aortic balloon pump.
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Although mortality after elective surgery is relatively
low,1,62 even a small improvement in survival may translate
into thousands of lives saved each year, given the enormous
number of surgical procedures performed worldwide. Physi-
cians treating surgical patients make everyday decisions on
which anesthetic techniques to apply, drugs to administer (or
avoid), and other nonsurgical strategies to use, often without
knowing whether those decisions actually affect mortality in
their patients. Guidelines can provide helpful information about
interventions that may inﬂuence mortality but also include
recommendations on many other aspects and therefore are often
dispersive, usually focused on a certain type of patient orsurgery, and have some limitations, including not always
strictly adhering to EBM.54 Through this consensus method-
ology, for the ﬁrst time to authors’ knowledge, all interventions
for which there was sufﬁcient, nonconﬂicting, and widely
agreed-upon evidence of an impact on perioperative mortality
in any adult surgical setting are listed together.
Despite the fact that the percentage of agreement was above
80% for most of the interventions improving survival, the
consistency between agreement and use in clinical practice
often was much lower; the same was true for the less-
expensive, widely available, and easy-to-perform interventions.
These ﬁndings may boost research on interventions with a high
level of agreement and therefore should be considered priority
Table 6. Percentage of Consistency Between Agreement and Practice
for Each Intervention Increasing Survival (1-11) and Increasing
Mortality (12-13)
Intervention Percentage Concordance
1. Volatile agents 79%
2. Tranexamic acid 75%
3. Perioperative hemodynamic optimization 73%
4. Insulin for glycemic control 73%
5. Neuraxial anesthesia 71%
6. Noninvasive ventilation 67%
7. Preoperative IABP in high-risk CABG 63%
8. Leuko-depleted red blood cell transfusion 62%
9. Levosimendan 56%
10. Selective decontamination of the digestive
tract
48%
11. Remote ischemic preconditioning 35%
12. Aprotinin 75%
13. Beta-blockers 71%
Abbreviations: CABG, coronary artery bypass grafting; IABP, intra-
aortic balloon pump.
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therefore increase their widespread use.
Overall, however, the percentage of agreement and the
consistency with both clinical use and the potential inclusion
into international guidelines suggested that EBM remains the
ideal benchmark of clinical practice, although greater efforts
should be made to remove or mitigate those factors (eg,
ingrained beliefs, “academic” traditions, discordant hints from
guidelines and opinion leaders, or simply the time needed by
physicians to digest recently published evidence) that prevent
clinical practice from readily adapting to the evolving evidence.
In this regard, the intervention of liberal transfusion strategy,
the most interesting major exclusion (Tables S1 and S2), is
emblematic. Although it was one of the topics with the highest
level of evidence (3 recent RCTs found a reduced mortality in
the perioperative setting with liberal transfusion strategies), it
has been excluded due to low agreement among web voters.
Along with the novelty of the message, this probably was due
to the existence of guidelines recommending exactly the
opposite. Notably, a recent meta-analysis63 conﬁrmed that
EBM was in favor of a liberal transfusion strategy in surgical
patients, and the results of the Transfusion Requirements in
Cardiac Surgery (TRICS) III trial64 hopefully will provide
clearer insights about this topic.
New Evidence
The body of biomedical literature is growing, and new
evidence on critical interventions is produced continuously. As
a consequence, additional evidence in support of a given
intervention has become available since the last web vote. In
particular, recent meta-analyses reported a survival beneﬁt
associated with the use of volatile agents in cardiac (but not
in noncardiac) surgery65; perioperative hemodynamic optimi-
zation66 and preoperative IABP67 also were associated with
beneﬁts.
In contrast, although RIPC was included among interventions
that may reduce mortality, 2 multicenter RCTs published by the
New England Journal of Medicine in the time interval betweenthe consensus and the writing of this manuscript demonstrated
that RIPC had no effect on clinically relevant outcomes,68,69
even if there still was the possibility that the use of propofol in
this setting may impair the beneﬁcial effects of RIPC. This
“pendulum effect,” however, is part of the nature of EBM.70
Importantly, recent trials on preoperative statin therapy in
statin-naïve patients offered another example of rapidly chang-
ing evidence. Even though statin therapy was associated with
reductions in mortality in some older RCTs and a meta-analysis
of RCTs,49–51 2 large RCTs published after the consensus vote
demonstrated not only that statins did not reduce mortality but
may instead increase the risk of developing acute kidney injury
in cardiac surgery patients.52,53 The authors of this study
therefore decided to exclude this intervention from those
associated with mortality reduction.
In addition to recently published evidence, ongoing studies
hopefully will provide deﬁnitive answers on several interven-
tions. Three large, multicenter RCTs on levosimendan use in
cardiac surgery currently are ongoing,71,72 and a large trial on
tranexamic acid use in coronary artery surgery (ATACAS trial)
recently has been completed.73 In addition, the authors
identiﬁed 132 studies registered as “currently recruiting” on
ClinicalTrials.gov on these 13 topics.Strengths and Limitations
The main strength of this study was that it combined EBM
with a unique methodology, which allowed the authors to
investigate the real views and the therapeutic approaches of
clinicians worldwide. The analysis of consistency between
agreement and use/avoidance showed that reported clinical
practice often adapts slowly to evidence and emphasized the
need to rethink the paths that lead from literature to clinical
practice. The reason for this discrepancy between agreement
and use/avoidances patterns was not investigated and was a
limitation of this study. Nevertheless, this ﬁnding provided an
interesting area for future investigation.
Conversely, the comparison with the previous consensus
process, of which this study represented an update, clearly
showed how fast evidence evolves. Furthermore, evidence now
is stronger for most of the previously included interventions,
and this may promote their implementation into clinical
practice.
Another strength of this study was the comparison of web
voters’ responses among different countries, which demon-
strated that healthcare probably is less “global” than it is
perceived to be. In particular, the opinions about the need to
include the interventions in future guidelines always were
signiﬁcantly different among different countries. This may
reﬂect, for example, a different attitude toward medico-legal
issues or different local cultures. Unfortunately, the reason for
such differences among countries was not investigated.
The rapid change of evidence also was a limitation of this
study, as reﬂected by the new evidence on some of the
interventions (eg, RIPC, statins) that has become available
since the ﬁnal web vote. Lack of deﬁnitive evidence on
different interventions has been acknowledged during the
consensus conference and led to position statements that could
be classiﬁed as conditional sentences (“may reduce”) and
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decided to keep their survey as simple as possible by providing
only 3 possible answers to the statements (agree, not agree, do
not know). Although this might be a limitation, it nevertheless
allowed the authors to determine which topics physicians all
over the world considered to be supported by the strongest
evidence as more important and therefore should be imple-
mented most easily, should a deﬁnitive trial be performed.
When developing the survey, the authors did not separate the
possibility to agree with the effect of the intervention on
mortality from the possibility to agree with the need for further
investigation, and the authors acknowledge that this was a
limitation of this study. Nevertheless, it is difﬁcult to believe
that someone who agrees that a certain intervention may save
lives would not be willing to test the same intervention to
obtain deﬁnitive evidence.
Other limitations were shared with the previous consensus
process and included the scarcity of randomized research in the
perioperative setting, the possibility that many other interventions
showing favorable effects on important outcomes other than
mortality may be of similar value on survival, and the lack of
any detail (deﬁnitions, doses, timing, odds ratios, conﬁdence
intervals, to name but a few) about the included interventions,
which are only listed and very brieﬂy contextualized. However, a
textbook recently was dedicated to the detailed discussion of all the
interventions included in the previous consensus process,74 and a
second edition detailing the updated interventions is underway.CONCLUSIONS
This updated international web-based consensus conference
process identiﬁed 13 interventions supported by randomized
evidence suggesting their role in reducing or increasing
perioperative mortality in adults undergoing any surgical
intervention. Moreover, the analysis of web voting conﬁrmed
that there is a gap between evidence and clinical practice
and that both the perception of medical literature and the
clinical conduct of physicians are signiﬁcantly different
among countries for many of the included interventions. Future
research and funding should better deﬁne the role of
these interventions and major exclusions and should investigate
the possible means to reduce both the gap existing
between evidence and clinical practice and the differences
among various countries. It is desirable that at least the
most robust among the identiﬁed interventions be discussed
soon in international guidelines on perioperative mortality
reduction.
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